|
FDA | CDER | Small Business and Industry Assistance (SBIA)
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms
|
|
|
November 21, 2024 | 1:00 PM - 3:00 PM ET
|
|
|
This webinar will provide an update and overview on the final M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms guideline including major changes from the draft guideline and FDA’s current bioequivalence (BE) guidance, delineate FDA’s planning on the implementation of M13A, and address questions and provide clarifications based on questions/comments received during public consultation of the draft guideline.
|
|
CONTINUING EDUCATION (CE)
Real-time participation is required for the certificate of attendance, which can be used in support of CEs for the following professional organizations: RAPS, SOCRA, SQA, and ACRP. Certificates are only available during the two weeks post-event. For more information, see details on our webpage.
|
|
|
The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research provides guidance, education and updates for regulated industry.
|
|
|
|
|
|
